Transthyretin stabilizer targeting for transthyretin amyloid cardiomyopathy: A systematic review and meta-analysis
Medicina Clínica · 2025
DOI: 10.1016/j.medcli.2025.107200 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medicina Clínica, 2025. Verfasst von João Victor de Oliveira Ramos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil. Electronic address: ramosjoaovictor9713@gmail.com. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin, Cardiomyopathies. Die Arbeit nennt 71 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease caused by cardiac amyloid deposition. Transthyretin stabilizers (TTRS) are a potential treatment, but their efficacy and safety remain uncertain. This study aims to evaluate the effects of TTRS on all-cause mortality, functional capacity, quality of life, and adverse events in ATTR-CM patients. METHODS: A systematic review and meta-analysis was conducted in February 2025 using Cochrane Central, PubMed, and Embase to identify clinical trials and observational studies comparing TTRS versus no-TTRS therapies. Two reviewers independently assessed study eligibility and extracted data. Outcomes were analyzed using odds ratios (OR) and mean differences (MD) with 95% confidence intervals. Heterogeneity was evaluated using I2 statistics, and sensitivity analyses were performed where appropriate. Risk of bias was assessed using ROBINS-I V2 and RoB 2 tools. RESULTS: Seventeen studies with 5209 participants (2399 TTRS; 2810 controls) were included. TTRS significantly reduced all-cause mortality (OR 0.20; 95% CI 0.11-0.37; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil. Electronic address: ramosjoaovictor9713@gmail.com.
- Medical Sciences Center, Federal University of Paraíba, João Pessoa, Brazil.
- Multicampi School of Medical Sciences, Federal University of Rio Grande do Norte, Caicó, Brazil.
- Lauro Wanderley University Hospital, Department of Internal Medicine, Federal University of Paraíba, João Pessoa, Brazil.
Zitieren
APA
de Oliveira Ramos, J. V., Andrade Fernandes, J. V., de Abrantes Formiga, Y. G., de Oliveira Ferreira, C. H., de Lima Beltrão, F. E., & Tavares de Melo, M. D. (2025). Transthyretin stabilizer targeting for transthyretin amyloid cardiomyopathy: A systematic review and meta-analysis. Medicina Clínica. https://doi.org/10.1016/j.medcli.2025.107200
Vancouver
de Oliveira Ramos JV, Andrade Fernandes JV, de Abrantes Formiga YG, de Oliveira Ferreira CH, de Lima Beltrão FE, Tavares de Melo MD. Transthyretin stabilizer targeting for transthyretin amyloid cardiomyopathy: A systematic review and meta-analysis. Medicina Clínica. 2025. doi:10.1016/j.medcli.2025.107200
BibTeX
@article{deOliveiraRamos2025,
author = {de Oliveira Ramos, João Victor and Andrade Fernandes, João Vitor and de Abrantes Formiga, Yan Gadelha and de Oliveira Ferreira, Carlos Henrique and de Lima Beltrão, Fabyan Esberard and Tavares de Melo, Marcelo Dantas},
title = {Transthyretin stabilizer targeting for transthyretin amyloid cardiomyopathy: A systematic review and meta-analysis},
journal = {Medicina Clínica},
year = {2025},
doi = {10.1016/j.medcli.2025.107200}
}
EUVIMED